Rocket Pharmaceuticals, Inc.RCKTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank15
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-190.01M
↓ 65% vs avg
Percentile
P15
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-115.04M
Historical baseline
PeriodValueYoY Change
2025$-190.01M+9.4%
2024$-209.72M-7.6%
2023$-194.92M-9.4%
2022$-178.14M-47.0%
2021$-121.16M-62.3%
2020$-74.64M-15.4%
2019$-64.66M-20.2%
2018$-53.79M-106.0%
2017$-26.11M+29.9%
2016$-37.27M-